Skip to content

Computer Guided Visco Supplementation in the Management of Internal Derangement of Temporomandibular Joint

Evaluation of Computer-guided Visco Supplementation in the Management of Internal Derangement of Temporomandibular Joint (a Randomized Controlled Clinical Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06667791
Enrollment
20
Registered
2024-10-31
Start date
2024-05-03
Completion date
2024-10-24
Last updated
2024-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorder

Brief summary

Background: The intra-articular injection is considered the first line of minimally invasive treatment in TMJ-ID patients who do not respond to conservative treatment. Image-guided puncture technique has emerged to add safety, reliability, convenience, and decrease the need for correcting the puncture point. Aim of the study: To evaluate the feasibility and clinical outcomes of computer-guided superior joint space injection of sodium hyaluronate in the treatment of temporomandibular joint disorder (TMJ-ID) compared with conventional injection

Interventions

OTHERComputer guided sodium hyaluronate injections

Patients will be treated with Computer guided sodium hyaluronate injections in superior TMJ space

OTHERconventional sodiumhyaluronate injections

Patients will be treated with conventional sodium hyaluronate injections in superior TMJ space

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\. Patients diagnosed with internal derangement according to Wilkins stage I and II. * Patients who would not respond to conservative treatment as a first line of treatment.

Exclusion criteria

* Patients with Wilkins stage III, IV, V. * History of mandibular fracture. * Lactating, pregnant or planning pregnancy women. * Known hypersensitivity to hyaluronic acid or clear biocompatible photopolymer resin.

Design outcomes

Primary

MeasureTime frameDescription
Change in TMJ dysfunctionBaseline, 1 month, and 3 monthsA modified version of Helkimo's clinical dysfunction index (Di) is be calculated to assess the TMJ dysfunction as follows: * Maximum unassisted mouth opening range: Opening range will be determined by asking the patient to gently open mouth and measure the distance between upper and lower central incisors. * Mandibular deviation during opening: Patients will be asked to open mouth gently and deviation will be noted between maxillary and mandibular midline, score 0 - if \<2 mm, score 1 - if 2-5 mm, and score 5 - if \>5 mm
change in pain scoreBaseline,1 months, and 3 monthsPain level was determined by the patient's self-assessment using a visual analog scale (VAS) from zero to 10 (0 is pain-free and 10 is severe intolerable pain).

Secondary

MeasureTime frameDescription
Duration of operationBaselineTotal procedural time consumed starting from the application of topical antiseptic up to the end of the procedure.
Number of Needle RelocationBaselineThe need to relocate the needle after first puncture of both needles will be used to compare between the efficacies of the computer guided arthrocentesis guide and the conventional free hand arthrocentesis.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026